Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lijnen, H.R.
Right arrow Articles by Collen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lijnen, H.R.
Right arrow Articles by Collen, D.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Stromelysin-1 (MMP-3)-Independent Gelatinase Expression and Activation in Mice

H.R. Lijnen, J. Silence, B. Van Hoef, and D. Collen

From the Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium.

A potential physiological role of stromelysin-1 (MMP-3) in the expression or activation of gelatinase A (MMP-2) or gelatinase B (MMP-9) in the wall of injured arteries was studied with the use of homozygous MMP-3-deficient (MMP-3-/-) mice. One week after perivascular electric injury of the carotid or femoral artery in wild-type (MMP-3+/+) or MMP-3-/- mice, 70 kD and 65 kD proMMP-2 levels were enhanced by twofold to fourfold, with corresponding increases of 20- to 40-fold for active 61 kD and 58 kD MMP-2, and of 10- to 80-fold for 94 kD proMMP-9. Active MMP-2 species represented approximately one third of the total MMP-2 concentration for both MMP-3+/+ and MMP-3-/- mice. Active 83 kD MMP-9 was not detected in noninjured carotid or femoral arteries, whereas one week after injury its contribution to the total MMP-9 level was 11% to 18% for MMP-3+/+ and MMP-3-/- mice. Immunostaining of arterial sections confirmed enhanced expression of both MMP-2 and MMP-9 after vascular injury. Double immunostaining showed colocalization of MMP-9 with macrophages in the adventitia, whereas MMP-2 was also detected mainly in the adventitia but failed to colocalize with smooth muscle cells. Cell culture experiments confirmed comparable ratios of active versus latent MMP-2 in skin fibroblasts and smooth muscle cells derived from MMP-3+/+ and MMP-3-/- mice. Addition of plasmin(ogen) did not significantly affect activation of proMMP-2. In MMP-3+/+ and MMP-3-/- macrophages, comparable levels of 94 kD proMMP-9 were detected, and plasmin(ogen)-mediated conversion to 83 kD MMP-9 was obtained in both genotypes. These data thus indicate that proMMP-2 activation may occur via a plasmin- and MMP-3-independent mechanism, whereas plasmin can directly activate proMMP-9 via a MMP-3-independent mechanism.

Blood, Vol. 91 No. 6 (March 15), 1998: pp. 2045-2053
© 1998 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
S. H. Cho, C. H. Ryu, and C. K. Oh
Plasminogen Activator Inhibitor-1 in the Pathogenesis of Asthma
Experimental Biology and Medicine, February 1, 2004; 229(2): 138 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-P. Han, Y.-D. Nien, and W. L. Garner
Tumor Necrosis Factor-alpha -induced Proteolytic Activation of Pro-matrix Metalloproteinase-9 by Human Skin Is Controlled by Down-regulating Tissue Inhibitor of Metalloproteinase-1 and Mediated by Tissue-associated Chymotrypsin-like Proteinase
J. Biol. Chem., July 19, 2002; 277(30): 27319 - 27327.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Silence, F. Lupu, D. Collen, and H. R. Lijnen
Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation
Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1440 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J.-H. Yang, H. Sakamoto, E. C. Xu, and R. T. Lee
Biomechanical Regulation of Human Monocyte/Macrophage Molecular Function
Am. J. Pathol., May 1, 2000; 156(5): 1797 - 1804.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Tanaka, K. Arai, Y. Kitamura, and H. Matsuda
Matrix Metalloproteinase-9 Production, a Newly Identified Function of Mast Cell Progenitors, Is Downregulated by c-kit Receptor Activation
Blood, October 1, 1999; 94(7): 2390 - 2395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ramos-DeSimone, E. Hahn-Dantona, J. Sipley, H. Nagase, D. L. French, and J. P. Quigley
Activation of Matrix Metalloproteinase-9 (MMP-9) via a Converging Plasmin/Stromelysin-1 Cascade Enhances Tumor Cell Invasion
J. Biol. Chem., May 7, 1999; 274(19): 13066 - 13076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-P. Han, T.-L. Tuan, M. Hughes, H. Wu, and W. L. Garner
Transforming Growth Factor-beta - and Tumor Necrosis Factor-alpha -mediated Induction and Proteolytic Activation of MMP-9 in Human Skin
J. Biol. Chem., June 15, 2001; 276(25): 22341 - 22350.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1998 by American Society of Hematology         Online ISSN: 1528-0020